1. Home
  2. LOB vs NBTX Comparison

LOB vs NBTX Comparison

Compare LOB & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Oak Bancshares Inc.

LOB

Live Oak Bancshares Inc.

HOLD

Current Price

$40.76

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$35.60

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOB
NBTX
Founded
2008
2003
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
LOB
NBTX
Price
$40.76
$35.60
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$43.00
$36.00
AVG Volume (30 Days)
253.8K
55.9K
Earning Date
04-22-2026
03-31-2026
Dividend Yield
0.32%
N/A
EPS Growth
31.95
N/A
EPS
0.60
N/A
Revenue
N/A
N/A
Revenue This Year
$35.52
$58.17
Revenue Next Year
$16.03
N/A
P/E Ratio
$68.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.36
$4.57
52 Week High
$42.89
$57.14

Technical Indicators

Market Signals
Indicator
LOB
NBTX
Relative Strength Index (RSI) 65.86 46.28
Support Level $39.43 $30.15
Resistance Level $42.72 $38.29
Average True Range (ATR) 0.99 2.68
MACD 0.25 -0.03
Stochastic Oscillator 85.08 60.06

Price Performance

Historical Comparison
LOB
NBTX

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: